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Introduction 
The thyroid hormone plays an essential role in 
the growth, differentiation and development of 
virtually all tissues. It also impacts numerous 
metabolic pathways, making it a significant 
factor in maintaining metabolic homeostasis. 
The two forms of thyroid hormone, 
triiodothyronine (T3), which is more potent, and 
thyroxine (T4), which is more abundant, can have 
effects on many different cellular components 
(1). However, they mostly regulate the 
transcription of target genes by binding to their 
specific intranuclear receptors, found in several 
different isoforms (1, 2). Thyroid hormones also 
affect the female reproductive system, which is 
why dysfunction of the thyroid gland can 
subsequently lead to disturbances of the 
menstrual cycle and fertility issues (2). 
Thyroid dysfunction, which leads to changes in 
circulating thyroid hormone levels, manifests 
itself as either hyperthyroidism or 
hypothyroidism. Hypothyroidism is the more 
prevalent variant and is linked to thyroid 
autoimmunity. Autoimmune thyroid disease 
(AITD) is the most prevalent cause of 
hypothyroidism in women of reproductive age 
(3, 4). Elevated levels of thyroid autoantibodies, 
such as thyroid peroxidase autoantibodies (TPO-
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Ab) and thyroglobulin autoantibodies (TG-Ab) 
induce chronic inflammation in the thyroid 
gland, which leads to the loss of functional 
tissue. Hypothyroidism can manifest itself with 
typical signs and symptoms such as fatigue, 
constipation, depression, thinning hair, cold 
intolerance, bradycardia, hoarseness, etc. It can 
also be subclinical (SCH), which is classically 
defined as an increase in thyroid-stimulating 
hormone (TSH) concentrations over the upper 
limit of normal range (4.5 – 5.0 mIU/L) with 
normal fT4 levels (5). 
Infertility is defined as an inability to conceive 
after at least 12 months of continuous 
intercourse without the use of contraception. Its 
current prevalence among couples ranges 
between 10 – 15% and has not changed 
significantly over the past few decades (6 - 8). 
Because of the effects thyroid hormone has on 
the ovaries (e.g., maturation of oocytes) and 
endometrial tissue, it is believed that AITD might 
play a role in the pathogenesis of infertility. 
Therefore, this review aims to interpret data 
collected on this subject thus far and summarize 
published studies to assess the association 
between AITD and infertility. 
Pathophysiological links between 
autoimmune thyroid disease and 
infertility 
Since AITD is the most common endocrine 
disorder in women of reproductive age, its 
effects on fertility have been investigated 
extensively and in detail. Nevertheless, a clear 
pathophysiological link connecting the two 
morbidities has not been identified and available 
data suggesting the prevalence of women with 
both AITD and infertility varies from study to 
study. Furthermore, interpretation of data from 
published studies on this subject matter is 
challenging due to several reasons, mostly 
relating to study designs and their flaws — 
retrospective studies providing incomplete 
information, small sample sizes, measurements 
of different thyroid antibodies, different 
populations investigated (heterogeneity of 
ethnicities and geographical locations), etc. 
Variations in SCH definitions and TSH ranges 
additionally contribute to the complexity of data 
interpretation. 
The role of thyroid hormones 
There is a clear connection between the thyroid 
gland and its hormones and the female 
reproductive system. Thyroid hormone 
receptors are expressed in the ovary and the 
endometrium. Furthermore, following egg 
fertilization, the thyroid hormone plays a role in 
the process of implantation and placentation (9). 
Generally, the proposed pathophysiological 
mechanisms contributing to infertility in women 
with AITD are either thyroid-dependent or 
thyroid-independent. Multiple studies have 
been conducted that aimed to establish the 
incidence of AITD in infertile women, as well as 
to connect AITD with certain morbidities 
affecting the female reproductive system. When 
observing the data collected and conclusions 
reached in each of those studies, it can be said 
that there is a significantly increased incidence 
of AITD in infertile women compared to controls 
(10 – 14). In a Danish study (10), conducted on 
11,254 women, the conclusion reached was that 
higher TSH levels and higher TPO-Ab levels 
affect fertility. A study by Poppe et al. (11) 
demonstrated significantly higher levels of TSH 
in infertile subjects compared to controls (1.3 vs 
1.1 mIU/L), however, TSH levels above or below 
the normal range were not more prevalent in 
infertile subjects (with fT4 levels within the 
normal range), indicating that women suffering 
from AITD might be affected by fertility issues 
even though they might seemingly be in a 
euthyroid state. In addition, women with AITD 
who are able to conceive are not without risk 
during pregnancy — a recent study among 
10,990 patients, part of the FASTER (First and 
Second Trimester Evaluation of Risk) trial, shined 
a light on the connection between thyroid 
autoimmunity and pregnancy risks. It showed 
that there was an increased risk for preterm 
premature rupture of membranes when both 
TPO-Abs and TG-Abs were present in both the 
first and second trimester (15). On the other hand, 
there have been studies with different results 
and outcomes. A study by Abalovich et al. (16) 
observed a higher prevalence of SCH, but not 
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AITD, in 244 subjects consulting on infertility, 
providing an example of contradictory data 
making the interpretation difficult, as mentioned 
earlier. Another example is a study by Plowden 
et al. (17), part of the EAGeR (Effects of Aspirin in 
Gestation and Reproduction) trial. They found 
that there was no difference in the delay of 
pregnancy in women with TSH of at least 2.5 
mIU/L or women with thyroid autoantibodies, 
compared with those with TSH under 2.5 mIU/L 
or without autoantibodies.  
Couples undergoing ART (assisted reproductive 
technologies) treatments are a group of interest 
in this context. In a systematic review and meta-
analysis of articles describing ART outcomes in 
the context of AITD, Busnelli et al. (18) concluded 
that AITD does not impact the outcome of ART 
treatments (IVF, ICSI) in terms of the number of 
oocytes retrieved and the likelihood of 
fertilization, implantation and clinical pregnancy. 
However, a wider implication similar to the one 
in the FASTER trial was made, that the presence 
of thyroid autoantibodies might have harmful 
effects on the course of the pregnancy, with an 
increased risk of miscarriage and decreased 
chance of live birth. 
Poppe et al. also showed that elevated levels of 
TPO-Abs were higher in infertile subjects, while 
the highest prevalence of positive antibodies 
among all subgroups of infertility was observed 
with endometriosis (11). It is a benign condition 
also linked to altered immune conditions, where 
endometrial tissue appears outside of the 
uterus, most commonly in the pelvis, inducing a 
chronic inflammation (19). Endometriosis in the 
context of AITD has been investigated, but the 
results have been contradictory. While the study 
by Kim et al. and two other studies (16, 20) 
reported a higher prevalence of endometriosis 
in women with AITD versus controls, a study by 
Petta et al. (21) showed that the prevalence of 
AITD was similar in a group of subjects with 
endometriosis and in a control group. A more 
recent study identified anti-laminin-111 
autoantibodies as having a potentially major role 
in the pathogenesis of endometriosis-
associated infertility (22). Outside of the 
endometrium, research has been conducted 
that showed that the source of fertility issues 
among women with AITD might be the ovary.  
Monteleone et al. (23) hypothesized that the 
critical source of female infertility due to AITD 
was in the ovarian follicle itself. Their study 
showed that TG-Abs and TPO-Abs were 
measurable in all samples of follicular fluid and 
serum drawn from subjects with AITD, while 
they were absent in controls. Furthermore, all 
subjects with AITD were in a euthyroid state, 
which suggested that the absence of 
progression of thyroid hormone status towards 
hypothyroidism due to AITD does not exclude 
issues with fertility. Expanding on that theory, 
Kelkar, et al. (24) demonstrated that human anti-
zona pellucida antigens reacted to murine 
thyroid tissue, therefore suggesting their 
similarity in antigens, which suggests, in turn, 
that zona pellucida may be affected by thyroid 
autoantibodies. A very common ovarian disorder 
that may be connected to AITD is polycystic 
ovary syndrome (PCOS). Thought to be one of 
the most common endocrinopathies in women 
(6.5 – 8 %), it is a complex disease that is 
multifactorial in its etiology (genetics, obesity, 
sedentary lifestyle, intrauterine androgen 
exposure, etc.) It is characterized by 
hyperandrogenism, increased LH-to-FSH ratio, 
poor glucose tolerance and hyperinsulinemia 
and over long-term, it can cause infertility and 
carries an increased risk for cardiovascular 
diseases, malignancies, type 2 diabetes mellitus 
and psychiatric disorders (25). A threefold higher 
prevalence of AITD in subjects with PCOS was 
demonstrated in a study on 175 subjects, 
compared to 168 controls, which was, according 
to the authors of the study, partly correlated with 
an increased estrogen-to-progesterone ratio 
(26). Further showing that the ovary is a key 
organ when investigating infertility in women 
with AITD, in a group of 244 subjects consulting 
on infertility, AITD prevalence reached statistical 
significance only in those with premature 
ovarian failure, which the authors believed to be 
the result of a shared autoimmune etiology 
between the two morbidities (16). 
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Thyroid hormone - independent immunological 
mechanisms 
Independently of the thyroid, multiple 
immunological mechanisms have been 
described as potential contributors to impaired 
fertility and fecundity in individuals with AITD. A 
dominant Th1 immune response promotes 
inflammation evoked through cell-mediated 
mechanisms, which is harmful for pregnancy. 
Th2 cell subsets, on the other hand, regulate and 
control the inflammation and tissue injury 
implemented by Th1 reactions, as well as 
protect against autoimmune damage (27). The 
regulatory mechanisms and balance of Th1 and 
Th2 cells are impaired in women with fertility and 
fecundity issues, with multiple studies 
confirming a distinct Th1 bias (28, 29), even in the 
endometrial tissue itself (30). A study by Kwak-
Kim et al. (30) showed significantly higher 
Th1/Th2 ratios of TNF-alfa/IL-4 and TNF-
alfa/IL-10 in both women with recurrent 
pregnancy losses and women with multiple 
implantation failures, while IFN-gama/IL-4, IFN-
gama/IL-10 were additionally higher in women 
with recurrent pregnancy losses. Links between 
impaired T-cell immunity and thyroid 
autoimmunity have recently been made. TNF-
alfa/IL-10 T-cell ratios were significantly 
increased in women with AITD (12), thus showing 
that thyroid antibodies can serve as markers for 
abnormal immunity, which is an important factor 
in impaired fertility. When observing abnormal 
B-cell function and its potential contribution to 
infertility in women with AITD, a clear connection 
between the presence of certain non-organ 
specific antibodies (NOSAs) and infertile women 
with AITD has not been proven yet. Kim et al. (12) 
reported that women with AITD did not have a 
higher prevalence of antiphospholipid 
antibodies (APAs), but did have a higher 
prevalence of NOSAs than women with no 
thyroid antibodies. One study suggested that 
NOSAs, in addition to TPO-Abs and TG-Abs, may 
serve as independent risk markers for repeated 
pregnancy loss in women with AITD, but no such 
statement was made for unexplained infertility 
(31). Aggravation of infertility in women with 
concurrent thyroid autoimmunity and other 
systemic autoimmune diseases has also been 
described, specifically systemic lupus 
erythematosus (SLE) and Sjogren's disease (32, 
33). In addition to effects T-cells and B-cells 
might have on the reproductive system, 
hyperactive and overproduced natural killer (NK) 
cells can also infiltrate the endometrial tissue 
and potentially alter the body's immune 
response, thus affecting fertility (34). TSH has 
been shown to have a stimulatory effect on NK 
cells (35) and studies have described increased 
levels and cytotoxicity of NK cells in AITD (12, 36 
- 38). Therefore, NK cells are an additional 
potential contributor in the pathogenesis of 
infertility in women with AITD. 
Autoimmune thyroid disease, infertility and 
nutritional deficiencies 
Yet another contributor linked to both AITD and 
infertility is vitamin D deficiency. As an 
omnipresent protein, vitamin D plays a key role 
in the calcium and phosphate metabolism. It has 
also been identified as a beneficial factor in 
many morbidities, including autoimmune 
diseases, cardiovascular diseases and 
malignancies (39). Vitamin D deficiency (< 10 
ng/ml), on the other hand, is, among other 
things, linked to both AITD and infertility. Kivity et 
al. (40) found that vitamin D deficiency was 
significantly more prevalent in subjects with 
AITD than in controls. Furthermore, vitamin D 
deficiency correlated to the presence of thyroid 
antibodies and abnormal thyroid function. In the 
context of fertility, vitamin D has been identified 
as mandatory for reproductive function in the 
murine model (41). Vitamin D deficient rats 
demonstrate, among other behavioral patterns 
and physiological changes affecting their 
reproductive systems, a diminished fertility 
capacity (42, 43). In humans, the vitamin D 
receptor (VDR) is expressed in the ovary, the 
endometrium and even the placenta. 
Furthermore, vitamin D is involved in better IVF 
outcomes, it plays a role in PCOS (deficiency is 
linked to obesity and metabolic morbidities) and 
it also affects the regularity of menstrual cycles 
and influences the production of sex hormones 
(44). With all that in mind, it is clear how vitamin 
D deficiency can contribute to both AITD and 
infertility. 
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There are numerous other microelements and 
vitamins that play a role in the physiology of 
thyroid function, so their deficiency, overload or 
perhaps impaired functionality might also play a 
role in the development of thyroid autoimmunity 
and be linked to infertility. These effects haven't 
been extensively researched, but we know that 
microelements such as magnesium, iodine, 
selenium and zinc, as well as other molecules 
such as riboflavin, vitamin C and coenzyme Q10 
have been associated with different forms of 
thyroid disease. Magnesium deficiency is the 
basis of mitochondrial dysfunction which can 
explain changes associated with thyroid 
dysfunction (45). An iodine overload increases 
the risk for an immune reaction, which 
additionally increases with selenium (Se) 
deficiency (46). Se is a necessary trace mineral 
because of its anti-inflammatory and antioxidant 
properties. While a study by Moncayo et al. (47) 
did not show a correlation between Se 
deficiency and thyroid autoantibodies, there 
have been several studies that showed lower Se 
levels in patients with Hashimoto thyroiditis (48, 
49). Se levels were significantly decreased in 
patients with subacute or silent thyroiditis (47). 
However, Se supplementation during 
pregnancy and postpartum reduces 
inflammation in the thyroid and lowers the risk of 
hypothyroidism (50), while it decreases 
autoantibody levels and improves the 
ultrasound structure of the thyroid in patients 
with Hashimoto's thyroiditis (51). Antioxidant 
enzymes also depend on the availability of 
copper and zinc. A study by Stolinska et al. (52) 
did not confirm, however, that zinc 
supplementation in patients with normal zinc 
levels can affect thyroid metabolism. While 
riboflavin, vitamin C and coenzyme Q10 have 
been researched in the context of thyroid 
dysfunction, there is insufficient data to show a 
link between deficiency, overload or dysfunction 
of those antioxidants with AITD, especially in 
correlation with infertility (53, 54).  
Hypothyroidism has also been associated with 
hyperprolactinemia - elevated levels of 
thyrotropin-releasing hormone (TRH) and TSH 
cause increased secretion of prolactin. Studies 
have shown that women of fertile age are most 
commonly affected by hyperprolactinemia as 
well as its presence in SCH, showing yet another 
consequence of this silent morbidity (55, 56). It 
can also impair fertility, since elevated prolactine 
levels and the pulsatile GnRH secretion may 
lead to a delayed LH response and affect corpus 
luteum function (56 – 58).  
Finally, thyroid antibodies could also inhibit the 
activity of human chorionic gonadotropin (hCG) 
on the corpus luteum due to cross-reactivity that 
has been observed between hCG and TSH. The 
corpus luteum plays a key role in supporting and 
maintaining a pregnancy in the first trimester 
through progesterone and estrogen secretion 
and is largely dependable on hCG. This 
pathophysiological mechanism doesn't cause 
infertility per se, but it may impair fecundity, 
since TSH receptor blocking antibodies could 
also block luteinizing hormone (LH) and hCG 
receptors, causing a decrease in steroid 
hormone production, resulting in spontaneous 
miscarriages (59). 
The American Thyroid Association published 
Guidelines for the Diagnosis and Management of 
Thyroid Disease During Pregnancy and the 
Postpartum in 2017.  They stated that evaluation 
of serum TSH concentration is recommended 
for all women seeking care for infertility. 
Additionally, they recommended levothyroxine 
(LT4) treatment for infertile women with overt 
hypothyroidism who desire pregnancy. 
However, no such recommendation was made 
for women suffering from AITD and euthyroid 
women due to insufficient evidence to 
determine whether or not LT4 therapy actually 
improves fertility in such cases. The only case 
where administration of low-dose LT4 was to be 
considered was in infertile women suffering 
from SCH, but were  thyroid antibody-negative 
(60). There are several examples of conflicting 
data and evidence that is insufficiently strong to 
suggest LT4 therapy improves the chances of 
achieving pregnancy. Negro et al. (61) 
investigated the effects of LT4 treatment in TPO-
Ab positive women undergoing assisted 
reproduction technologies (ART) and found that 
the pregnancy rate was not affected by 
treatment with LT4. In the study by Abalovich et 
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al (16), however, LT4 was prescribed to 34 
subjects with SCH and after 6 months of follow-
up, 44.1% achieved pregnancy. 
Conclusion 
AITD and infertility are two morbidities that have 
separately been widely investigated and 
detailed pathophysiological mechanisms for 
both entities have been described. However, 
there is a wide variety of overlapping factors that 
make it difficult to distinguish how and if AITD 
and infertility are interconnected. All the factors 
described in this review (abnormal lymphocyte 
production, a Th1 immune response bias, vitamin 
D deficiency, etc.) (Figure 1.) could be 
contributing to infertility as well as AITD to some 
extent, but the possibility remains that one or a 
few of them might have a more significant 
impact on the pathogenesis. Conflicting data 
and different study designs make shedding light 
on the interconnectedness of these morbidities 
difficult. There is even no consensus on the 
exact organ of origin of infertility caused by 
thyroid autoimmunity, with the uterus and the 
ovary both potentially playing roles and being 
targeted by the thyroid antibodies. 
Based on the findings of the studies, there is still 
an insufficient amount of evidence that would 
suggest levothyroxine treatment is a viable 
treatment option for infertile women suffering 
from AITD. Recommendations from 2015 have 
only been made for infertile women suffering 
from SCH, but who are thyroid antibody-
negative. Even in those cases, however, LT4 
treatment should simply be "considered". That is 
Figure 1. Clinical entities and pathophysiological mechanisms linking female infertility with AITD. (TSH – thyroid-stimulating 
hormone; SLE – systemic lupus erythematosus; NOSAs – non-organ specific antibodies; hCG – human chorionic gonadotropin; NK 
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why it is crucial to continue researching these 
two entities to potentially increase the chances 
for women to conceive and carry out a healthy 
pregnancy. 
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